Resmed Inc Drc Stock Net Income
| RSMDF Stock | USD 28.10 0.06 0.21% |
As of the 14th of February 2026, Resmed holds the Risk Adjusted Performance of 0.0555, coefficient of variation of 1687.98, and Variance of 12.53. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Resmed, as well as the relationship between them. Please check Resmed Inc DRC information ratio, and the relationship between the coefficient of variation and value at risk to decide if Resmed Inc DRC is priced some-what accurately, providing market reflects its current price of 28.1 per share. Given that Resmed has information ratio of 0.0395, we recommend you to check out Resmed Inc DRC's recent market performance to make sure the company can sustain itself at a future point.
Resmed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Resmed's valuation are provided below:Resmed Inc DRC does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Resmed |
Resmed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Resmed's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Resmed.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Resmed on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Resmed Inc DRC or generate 0.0% return on investment in Resmed over 90 days. Resmed is related to or competes with HOYA, WuXi AppTec, Fresenius, Terumo, Terumo Corp, WuXi AppTec, and Haleon Plc. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for t... More
Resmed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Resmed's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Resmed Inc DRC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0395 | |||
| Maximum Drawdown | 26.59 | |||
| Value At Risk | (1.22) | |||
| Potential Upside | 6.91 |
Resmed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Resmed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Resmed's standard deviation. In reality, there are many statistical measures that can use Resmed historical prices to predict the future Resmed's volatility.| Risk Adjusted Performance | 0.0555 | |||
| Jensen Alpha | 0.168 | |||
| Total Risk Alpha | (0.06) | |||
| Treynor Ratio | 0.3771 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Resmed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Resmed February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0555 | |||
| Market Risk Adjusted Performance | 0.3871 | |||
| Mean Deviation | 1.38 | |||
| Coefficient Of Variation | 1687.98 | |||
| Standard Deviation | 3.54 | |||
| Variance | 12.53 | |||
| Information Ratio | 0.0395 | |||
| Jensen Alpha | 0.168 | |||
| Total Risk Alpha | (0.06) | |||
| Treynor Ratio | 0.3771 | |||
| Maximum Drawdown | 26.59 | |||
| Value At Risk | (1.22) | |||
| Potential Upside | 6.91 | |||
| Skewness | (1.92) | |||
| Kurtosis | 12.72 |
Resmed Inc DRC Backtested Returns
At this point, Resmed is not too volatile. Resmed Inc DRC maintains Sharpe Ratio (i.e., Efficiency) of 0.0248, which implies the firm had a 0.0248 % return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Resmed Inc DRC, which you can use to evaluate the volatility of the company. Please check Resmed's Variance of 12.53, risk adjusted performance of 0.0555, and Coefficient Of Variation of 1687.98 to confirm if the risk estimate we provide is consistent with the expected return of 0.0864%. Resmed has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.53, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Resmed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Resmed is expected to be smaller as well. Resmed Inc DRC right now holds a risk of 3.48%. Please check Resmed Inc DRC skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Resmed Inc DRC will be following its historical price patterns.
Auto-correlation | 0.56 |
Modest predictability
Resmed Inc DRC has modest predictability. Overlapping area represents the amount of predictability between Resmed time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Resmed Inc DRC price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Resmed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 3.14 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Resmed Inc DRC reported net income of 779.44 M. This is 128.38% higher than that of the Healthcare sector and significantly higher than that of the Medical Instruments & Supplies industry. The net income for all United States stocks is 36.51% lower than that of the firm.
Resmed Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Resmed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Resmed could also be used in its relative valuation, which is a method of valuing Resmed by comparing valuation metrics of similar companies.Resmed is currently under evaluation in net income category among its peers.
Resmed Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 33.08 B | |||
| Shares Outstanding | 1.47 B | |||
| Shares Owned By Institutions | 7.93 % | |||
| Price To Earning | 28.58 X | |||
| Price To Book | 9.54 X | |||
| Price To Sales | 9.04 X | |||
| Revenue | 3.58 B | |||
| Gross Profit | 2.06 B | |||
| EBITDA | 1.18 B | |||
| Net Income | 779.44 M | |||
| Cash And Equivalents | 273.71 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 765.33 M | |||
| Debt To Equity | 0.27 % | |||
| Current Ratio | 2.80 X | |||
| Book Value Per Share | 6.36 X | |||
| Cash Flow From Operations | 351.15 M | |||
| Earnings Per Share | 0.55 X | |||
| Price To Earnings To Growth | 1.76 X | |||
| Target Price | 11.49 | |||
| Number Of Employees | 8.16 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 34.16 B | |||
| Total Asset | 5.1 M | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 5.1 M | |||
| Last Dividend Paid | 1.72 |
About Resmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Resmed Inc DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed Inc DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Resmed Pink Sheet
Resmed financial ratios help investors to determine whether Resmed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resmed with respect to the benefits of owning Resmed security.